Print this page

£100k support for multiple sclerosis research at Cambridge University

Thursday, 04 September 2014

Pioneering brain repair

Research at Cambridge University’s Clinical Neurosciences Department into multiple sclerosis (MS) was celebrated at a special charity evening held in Cambridge. Representatives from 25 local charities were invited to a supper at Freemasons’ Hall during which grants were awarded from both national and Cambridgeshire masonic charities.

The Grand Charity and the MSF have each made a grant of £50,000 towards a research project on the safety of the drug Bexarotene – capable of repairing brain damage during the early stages of MS. In 2011, a £100,000 grant from the Grand Charity supported the development of Alemtuzumab, a drug used to help treat leukaemia, by Dr Alasdair Coles – which is now licensed for use in Europe, Canada and Australia.